CN104435573A - 一种减缓癌痛的外用中药制剂及制法 - Google Patents
一种减缓癌痛的外用中药制剂及制法 Download PDFInfo
- Publication number
- CN104435573A CN104435573A CN201410659418.3A CN201410659418A CN104435573A CN 104435573 A CN104435573 A CN 104435573A CN 201410659418 A CN201410659418 A CN 201410659418A CN 104435573 A CN104435573 A CN 104435573A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- herba
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 82
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 206010058019 Cancer Pain Diseases 0.000 title claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 36
- 241000218176 Corydalis Species 0.000 claims abstract description 35
- 239000004863 Frankincense Substances 0.000 claims abstract description 32
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241001057584 Myrrha Species 0.000 claims description 36
- 241000717739 Boswellia sacra Species 0.000 claims description 31
- 241001648012 Saginae Species 0.000 claims description 31
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 29
- 241001489978 Eupolyphaga Species 0.000 claims description 27
- 241000241413 Propolis Species 0.000 claims description 14
- 229910052742 iron Inorganic materials 0.000 claims description 14
- 229940069949 propolis Drugs 0.000 claims description 14
- 235000021419 vinegar Nutrition 0.000 claims description 12
- 239000000052 vinegar Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 11
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 238000005202 decontamination Methods 0.000 claims description 7
- 230000003588 decontaminative effect Effects 0.000 claims description 7
- 238000005242 forging Methods 0.000 claims description 7
- 235000004611 garlic Nutrition 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 239000004570 mortar (masonry) Substances 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 244000245420 ail Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 50
- 201000011510 cancer Diseases 0.000 abstract description 41
- 208000002193 Pain Diseases 0.000 abstract description 35
- 230000036407 pain Effects 0.000 abstract description 35
- 230000000694 effects Effects 0.000 abstract description 13
- 240000007311 Commiphora myrrha Species 0.000 abstract description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000018716 Impatiens biflora Species 0.000 abstract 1
- 235000015912 Impatiens biflora Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 241001365733 Sagina japonica Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000005155 Tanacetum balsamita Nutrition 0.000 abstract 1
- 241000606265 Valeriana jatamansi Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 244000186071 dragons blood palm Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 238000002512 chemotherapy Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 240000002234 Allium sativum Species 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 238000001959 radiotherapy Methods 0.000 description 4
- 208000004371 toothache Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000001165 lymph node Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 240000004980 Rheum officinale Species 0.000 description 2
- 235000008081 Rheum officinale Nutrition 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- HPGCBEMVWCCLIT-AAGWESIMSA-N 1-[4-[(e)-3-phenylprop-2-enyl]piperazin-1-yl]butan-1-one;hydrochloride Chemical compound Cl.C1CN(C(=O)CCC)CCN1C\C=C\C1=CC=CC=C1 HPGCBEMVWCCLIT-AAGWESIMSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- 241000758795 Aristolochiaceae Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010005003 Bladder cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- 235000008671 Calycanthus floridus Nutrition 0.000 description 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000907904 Dipterocarpus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241000546273 Lindera <angiosperm> Species 0.000 description 1
- 244000148992 Lindera benzoin Species 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010060860 Neurological symptom Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000583586 Sagina Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 208000027499 body ache Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010023841 laryngeal neoplasm Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- XCKKIKBIPZJUET-VYKNHSEDSA-N morphine hydrochloride Chemical compound Cl.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O XCKKIKBIPZJUET-VYKNHSEDSA-N 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 210000001328 optic nerve Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011470 radical surgery Methods 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 206010046459 urethral obstruction Diseases 0.000 description 1
- 201000005112 urinary bladder cancer Diseases 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成:元胡3-7份、丹参6-12份、乌药3-8份、蚤休1-5份、土元1-5份、血蝎1-3份,细辛5-15份、透骨草6-13份、乳香7-14份、没药3-9份、大黄7-15份、白芷10-20份、冰片4-10份、漆姑草2-6份、蜘蛛香3-6份、麦饭石2-7份。该外用中药制剂对各种癌症效果显著,“不仅有止痛的功效,还有抗肿瘤的作用,能减轻癌症带来的痛苦,改善患者生存质量。”本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
Description
技术领域
本发明属中医中药领域,尤其是涉及一种减缓癌痛的外用中药制剂及制法。
背景技术
癌症是一大类恶性肿瘤的统称。癌细胞的特点是无限制地增生,使患者体内的营养物质被大量消耗;癌细胞释放出多种毒素,使人体产生一系列症状;癌细胞还可转移到全身各处生长繁殖,导致人体消瘦、无力、贫血、食欲不振、发热以及严重的脏器功能受损等等。与之相对的有良性肿瘤,良性肿瘤则容易清除干净,一般不转移、不复发,对器官、组织只有挤压和阻塞作用,但癌症(恶性肿瘤)还可破坏组织、器官的结构和功能,引起坏死出血合并感染,患者最终由于器官功能衰竭而死亡。
由于各种癌的发生部位不同,病理形态不同,以及发展阶段不同,因此会产生各种各样的临床表现。但癌症的早期往往症状很少,待发展到一定阶段后才渐渐表现出一系列症状和体征。一般将癌症的临床表现分为局部表现和全身性症状两个方面。
一、癌症的局部表现主要有:1、肿块:癌细胞恶性增殖所形成的,可用手在体表或深部触摸到。甲状腺、腮腺或乳腺的癌可在皮下较浅部位触摸到。肿瘤转移到淋巴结,可导致淋巴结肿大,某些表浅淋巴结,如颈部淋巴结和腋窝淋巴容易触摸到。至于在身体较深部位的癌症、胰腺癌等,则要用力按压才可触到。恶性肿瘤包括癌的肿块生长迅速,表面不平滑,不易推动;良性肿瘤则一般表面平滑,像鸡蛋和乒乓球一样容易滑动。2、疼痛:出现疼痛往往提示癌症已进入中、晚期。开始多为隐痛或钝痛,夜间明显。以后逐渐加重,变得难以忍受,昼夜不停。一般止痛药不起作用。疼痛一般是癌细胞侵犯神经造成的。3、溃疡:由于某些体表癌的癌组织生长快,营养供应不足,出现组织坏死所形成的。如某些乳腺癌可在乳房处出现火山口样或菜花样溃疡,分泌血性分泌物,并发感染时可有恶臭味。此外,胃、结肠癌也可形成溃疡,一般只有通过胃镜、结肠镜才可观察到。4、出血:癌组织侵犯血管或癌组织小血管破裂而产生的。如肺癌病人可咯血,痰中带血;胃、结肠、食管癌则可便血。5、梗阻:癌组织迅速生长而造成的梗阻。当梗阻部位在呼吸道即的生呼吸困难;食管癌梗阻食管则吞咽困难;胆道部位的癌可以阻塞胆总管而的生黄疸;膀胱癌阻塞尿道而出现排尿困难等。总之,因癌症所梗阻的部位不同而出现不同的症状。6、其它:颅内肿瘤可引起视力障碍(压迫视神经)、面瘫(压迫面神经)等多种神经系统症状;骨肿瘤侵犯骨骼可导致骨折;肝癌引起血浆白蛋白减少而致腹水等。
现在对于癌症的治疗,西医通常采用手术治疗、放射治疗或者化学治疗三者其一,或一同治疗的方法。手术治疗:通常包括根治性手术,姑息性手术,探查性手术。即以手术为手段完全切除病灶或者切除部分病灶,达到治愈或控制癌症的方法。放射治疗:简称放疗,是利用高能电磁辐射线作用于生命体,使生物分子结构改变,达到破坏癌细胞目的的一种治疗方法。放射能够治疗癌症是因为癌细胞对放射线敏感。目前临床上应用的放射线有X线治疗和r线治疗两种。化学治疗:化学疗法是将药物经血管带到全身,对身体所有细胞都有影响。这种疗法有时也称为“胞毒疗法”,因为所用药物都是有害的,甚至是带毒性的,体内细胞,无论是否恶性细胞,都受到破坏。
无论是采用手术治疗、放射治疗还是采用化学治疗,都对病人的身体造成极大的负担,且费用高昂,病患承受痛苦大。
发明内容
近年来,人们渐渐意识到了中药治疗癌症具有症状改善明显、毒副反应小、无耐药性等优势,针对现有西医治疗癌症的现状,本发明的目的之一在于提供一种治疗癌症的外用中药制剂,具有易操作、疗效显著的特点,并且它采用地方上较为常见的中药材作为原料,成本低廉。
本发明的上述目的是通过以下技术方案来实现的:
一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成:元胡3-7份、丹参6-12份、乌药3-8份、蚤休1-5份、土元1-5份、血蝎1-3份,细辛5-15份、透骨草6-13份、乳香7-14份、没药3-9份、大黄7-15份、白芷10-20份、冰片4-10份、漆姑草2-6份、蜘蛛香3-6份、麦饭石2-7份。
一种减缓癌痛的外用中药制剂,优选的方案,取下述重量配比的主要原料制备而成:元胡4-6份、丹参8-10份、乌药5-7份、蚤休2-4份、土元2-4份、血蝎1.5-2.5份,细辛8-13份、透骨草8-11份、乳香9-12份、没药5-7份、大黄10-12份、白芷13-18份、冰片6-8份、漆姑草3-5份、蜘蛛香4-5份、麦饭石3-6份。
一种减缓癌痛的外用中药制剂,最佳的方案,取下述重量配比的主要原料制备而成:元胡5份、丹参9份、乌药6份、蚤休3份、土元3份、血蝎2份,细辛10份、透骨草10份、乳香11份、没药6份、大黄11份、白芷15份、冰片7份、漆姑草4份、蜘蛛香4.5份、麦饭石5份。
一种减缓癌痛的外用中药制剂的制备方法,主要由下述步骤制备而成:
(1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡1-5小时,取出,置于微波炉内,80-90℃,烘1-5分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入白酒,密封静置10-20小时,取出,置于烧热的铁板上,摊匀,小火慢烘20-30分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加30-40℃的温水,武火煎开,煮沸1-6分钟,转文火煎40-60分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮10-20分钟,加入蜂胶后要一边煎煮一边搅拌,静置50-100分钟,取上清液,装瓶即得外用中药制剂。
上述制备方法,步骤(2)将土元和血蝎用白醋浸泡2-4小时(优选的,将土元和血蝎用白醋浸泡3小时)。
上述制备方法,步骤(2)置于微波炉内,83-88℃,烘2-4分钟(优选的,置于微波炉内,85℃,烘3分钟)。
上述制备方法,步骤(3)白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的1-5倍(优选的,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的2-4倍,更加优选的,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的3倍)。
上述制备方法,步骤(3)白酒的度数为40-55度(优选的,白酒的度数为48-52度,更加优选的,白酒的度数为50度)。
上述制备方法,步骤(4)至于砂锅内加33-38℃的温水,武火煎开,煮沸2-5分钟,转文火煎45-55分钟(优选的,至于砂锅内加35℃的温水,武火煎开,煮沸4分钟,转文火煎50分钟)。
上述制备方法,步骤(4)静置60-90分钟,取上清液(优选的,静置75分钟,取上清液)。
该外用中药制剂对癌症效果显著,不仅有止痛的功效,还有抗肿瘤的作用。本发明多选用地方常见药材,价格低廉,减轻了患者的经济负担。
各原料药的药理功效分别为:
元胡:元胡又名延胡索、玄胡,为罂粟科紫堇属多年生草本植物,与白术、芍药、贝母等并称“浙八味”,为大宗常用中药。性温,味辛苦,入心、脾、肝、肺,是活血化瘀、行气止痛之妙品,尤以止痛之功效而著称于世。
丹参:丹参又名赤参,紫丹参,红根等。性味苦,微寒。归心、肝经。有祛瘀止痛,活血通经,清心除烦之功效。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。
乌药:乌药别名:旁其、天台乌药、矮樟、矮樟根、鸡骨香、白叶柴,为樟科、山胡椒属植物,常绿灌木或小乔木,有香味,微苦,有刺激性清凉感。有行气止痛,温肾散寒的功效。
蚤休:中药蚤休为百合科植物七叶一枝花、金线重楼及其数种同属植物的根茎。其功能有:清热解毒,平喘止咳,熄风定惊,消肿止血。主治:痈肿,疔疮,瘰疬,喉痹,慢性气管炎,小儿惊风抽搐,蛇虫咬伤,妇女经血不调,跌打损伤。
土元:土元是地鳖的别名。属于昆虫,身体扁,棕黑色,雄的有翅膀,雌的无翅。抗肿瘤作用,地鳖虫对实验动物肿瘤有一定的抑制作用,体外实验结果表明:地鳖虫能抑制肝癌、胃癌细胞的呼吸.在试管内,用美兰法测得地鳖虫浸膏有抑制白血病患者白细胞的作用,但用瓦伯呼吸器法,则为阴性结果。
血蝎:血蝎是常用的珍贵中药材,它具有消炎、止血生肌、散瘀止痛之功效,用于中药各种血症的治疗,经临床证明,其对骨折、软组织损伤和咳血、呕血过多等多种血症,活血散瘀,定痛,止血生肌,敛疮。
细辛:细辛又名:华细辛、小辛、少辛、盆草细辛等,属马兜铃目,马兜铃科多年生草本;根状茎直立或横走,有多条须根,主治:祛风,散寒,行水,开窍。治风冷头痛,鼻渊,齿痛,痰饮咳逆,风湿痹痛。细辛既能外散风寒,又能内祛阴寒,同时止痛、镇咳功效较佳。
透骨草:透骨草又名药曲草,蝇毒草等。种子亦名急性子,茎亦名透骨草,均可入药,有活血化瘀、利尿解毒、通经透骨之功效。鲜草捣烂外敷,可治疮疖肿疼、毒虫咬伤。
乳香:乳香,本名薰陆,别名熏陆香、马尾香、乳头香、塌香、天泽香、摩勒香、多伽罗香等,为橄榄科常绿乔木的凝固树脂。调气活血,定痛,追毒。治气血凝滞、心腹疼痛,痈疮肿毒,跌打损伤,痛经,产后瘀血刺痛。
没药:没药,又名末药,其他还有明没药没药末药制没药炙没药醋炒没药生没药生明没药等别称。是一种活血、化瘀、止痛、健胃的中药。
大黄:大黄是《中国药典》收录的草药,药用来源为蓼科植物掌叶大黄、唐古特大黄或药用大黄的干燥根及根茎。具有攻积滞、清湿热、泻火、凉血、祛瘀、解毒等功效。
白芷:以根入药,有祛病除湿、排脓生肌、活血止痛等功能。主治风寒感冒、头痛、鼻炎、牙痛。赤白带下、痛疖肿毒等症,亦可作香料。
冰片:冰片,又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等,冰片主散郁火,能透骨热,治惊痫、痰迷、喉痹,舌胀、牙痛、耳聋、鼻息、目赤浮翳、痘毒内陷、杀虫、痔疮、催生,性走而不守,亦能生肌止痛。
蜘蛛香:为败酱科属植物蜘蛛香的根茎。成分:根和根茎主要含挥发性成分,还含有咖啡酸。药理:对中枢神经具有抑制作用,有抗肿瘤的作用。药性:辛,微苦,温。功能主治:理气和中,散寒除湿,活血消肿。
麦饭石:基原:为中酸性火成岩类岩石石英二长斑岩。成分:中华麦饭石主要成分有二氧化硅,氧化铝,氧化铁,氧化亚铁,氧化镁,氧化钙,氧化钠,氧化钾,二氧化钛,五氧化二磷,氧化锰,二氧化碳,以及氟、硫、锶、钡、铜、锌等微量元素。药性:《纲目》:“甘,温,无毒。”功用主治:解毒生肌,祛湿健脾。主治痈疽发背,痤疮,湿疹,脚气,痱子,手指皲裂,黄褐斑,牙痛,口腔溃疡,风湿痹痛,腰背痛,慢性肝炎,胃炎,痢疾,糖尿病,神经衰弱,外伤红肿,高血压病,老年性血管硬化,肿瘤,尿路结石。一般作保健用品。宜忌:外敷时需研极细末,否则易引起疼痛。
漆姑草:为是石竹科漆姑草属植物漆姑草的全草。成分:寒挥发油,皂甘和黄酮。药理:具有低抗癌症的作用,有镇咳、化痰之功效。药性:苦,辛,凉。归肝,胃经。功能主治:凉血解毒,杀虫止痒。
本发明外用中药制剂基于中医中药辩症治疗的原理。治疗更加全面,病灶处给药更加迅速,药效持久,标本兼治的癌症组方。对癌症有极好的治疗作用,对于因长期放化疗而羸弱的身体有极好的调理作用。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不被此限制。
实施例1 一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成(每份取10g):元胡3份、丹参6份、乌药3份、蚤休1份、土元1份、血蝎1份,细辛5份、透骨草6份、乳香7份、没药3份、大黄7份、白芷10份、冰片4份、漆姑草2份、蜘蛛香3份、麦饭石2份。
上述减缓癌痛的外用中药制剂的制备方法,步骤如下:
((1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡1小时,取出,置于微波炉内,80℃,烘1分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入40度的白酒,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的1倍,密封静置10小时,取出,置于烧热的铁板上,摊匀,小火慢烘20分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加30℃的温水,武火煎开,煮沸1分钟,转文火煎40分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮10分钟,加入蜂胶后要一边煎煮一边搅拌,静置50分钟,取上清液,装瓶即得外用中药制剂。
典型病例一:齐XX,男,50岁,山东省济阳人。症状:2010年11月29日因肝区剧痛就诊,检查发现肝脏有一肿瘤11x10cm。12月31日CT复查肿瘤增大至13x13cm,各种症状日益加重,卧床不起,确诊为晚期癌症,失去手术和放化疗机会。
使用实施例1所得外用中药制剂治疗10天,自感肝区疼痛症状减轻;使用本发明外用中药制剂治疗1个月,体力明显改善,自己可以起床并到室外散步;继续用药3个月,气色较之原来有很大改观,经医院复查,癌细胞无扩散现象,体重增加,生活质量较之西医治疗时有很大改观,心情比原来开朗,对生活有了新希望,目前正在持续使用中。
实施例2 一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成(每份取10g):元胡7份、丹参12份、乌药8份、蚤休5份、土元5份、血蝎3份,细辛15份、透骨草13份、乳香14份、没药9份、大黄15份、白芷20份、冰片10份、漆姑草6份、蜘蛛香6份、麦饭石7份。
上述减缓癌痛的外用中药制剂的制备方法,步骤如下:
(1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡5小时,取出,置于微波炉内,90℃,烘5分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入55度的白酒,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的5倍,密封静置20小时,取出,置于烧热的铁板上,摊匀,小火慢烘30分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加40℃的温水,武火煎开,煮沸6分钟,转文火煎60分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮20分钟,加入蜂胶后要一边煎煮一边搅拌,静置100分钟,取上清液,装瓶即得外用中药制剂。
典型病例二:李XX,女,49岁,山东省聊城人士,一直在外地打工,突然出现不明原因的全身酸疼无力的症状,刚开始吞咽疼痛久治不愈,后伴有严重咳嗽的症状,咯血,喉部明显肿大。经医院检查确诊为中期癌症。由于发现时已经错失了手术的机会,所以医生建议使用本发明所得外用中药制剂。
使用实施例2所得外用中药制剂治疗5天,咽部疼痛有所缓解;使用本发明外用中药制剂治疗2个月,喉部肿瘤缩小;使用本发明外用中药制剂治疗5个月,经医院复查后发现肿瘤进一步缩小,目前正在继续使用中。
实施例3 一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成(每份取10g):元胡4份、丹参8份、乌药5份、蚤休2份、土元2份、血蝎1.5份,细辛8份、透骨草8份、乳香9份、没药5份、大黄10份、白芷13份、冰片6份、漆姑草3份、蜘蛛香4份、麦饭石3份。
上述减缓癌痛的外用中药制剂的制备方法,步骤如下:
(1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡2小时,取出,置于微波炉内,83℃,烘2分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入48度的白酒,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的2倍,密封静置13小时,取出,置于烧热的铁板上,摊匀,小火慢烘23分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加33℃的温水,武火煎开,煮沸2分钟,转文火煎45分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮13分钟,加入蜂胶后要一边煎煮一边搅拌,静置60分钟,取上清液,装瓶即得外用中药制剂。
典型病例三:邱XX,女,56岁,山东省济阳县人。吃东西下咽困难,体重下降,间歇性胃部疼痛伴有严重呕吐,去医院诊断为早期癌症。病龄:5个月。使用本发明外用中药制剂治疗10天,疼痛有很大的缓解。
使用实施例3所得外用中药制剂治疗5天,疼痛症状减轻,食欲有所恢复;使用本发明外用中药制剂治疗4个月,去医院复查未发现癌症扩散;使用本发明外用中药制剂治疗5个月,肿瘤细胞变小,目前未发现癌症扩散。
实施例4 一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成(每份取10g):元胡6份、丹参10份、乌药7份、蚤休4份、土元4份、血蝎2.5份,细辛13份、透骨草11份、乳香12份、没药7份、大黄12份、白芷18份、冰片8份、漆姑草5份、蜘蛛香5份、麦饭石6份。
上述减缓癌痛的外用中药制剂的制备方法,步骤如下:
(1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡4小时,取出,置于微波炉内,88℃,烘4分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入52度的白酒,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的4倍,密封静置18小时,取出,置于烧热的铁板上,摊匀,小火慢烘28分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加38℃的温水,武火煎开,煮沸5分钟,转文火煎55分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮18分钟,加入蜂胶后要一边煎煮一边搅拌,静置90分钟,取上清液,装瓶即得外用中药制剂。
典型病例四:吴XX,男,45岁,山东省济南市人。症状:胃经常性隐痛,嗳气、呕吐,没有食欲,身体消瘦乏力,起初以为是工作太累的原因,没太在意,去年去医院检查,确诊是癌症晚期,并且癌细胞已经开始扩散,做化疗2个月,因忍受和承受不了化疗的不良反应及高昂费用而停止治疗,停止化疗后曾接受其他药物治疗,但是效果都不明显,无意中在网上看到本发明外用中药制剂,就买了1个月的使用。
使用实施例4所得外用中药制剂治疗5天,疼痛症状减轻,食欲有所恢复;使用本发明外用中药制剂治疗4个月,去医院复查未发现癌症扩散;使用本发明外用中药制剂治疗5个月,肿瘤缩小,目前未发现癌症扩散。
实施例5 一种减缓癌痛的外用中药制剂,取下述重量配比的主要原料制备而成(每份取10g):元胡5份、丹参9份、乌药6份、蚤休3份、土元3份、血蝎2份,细辛10份、透骨草10份、乳香11份、没药6份、大黄11份、白芷15份、冰片7份、漆姑草4份、蜘蛛香4.5份、麦饭石5份。
上述减缓癌痛的外用中药制剂的制备方法,步骤如下:
(1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡3小时,取出,置于微波炉内,85℃,烘3分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入50度的白酒,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的3倍,密封静置15小时,取出,置于烧热的铁板上,摊匀,小火慢烘25分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加35℃的温水,武火煎开,煮沸4分钟,转文火煎50分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮15分钟,加入蜂胶后要一边煎煮一边搅拌,静置75分钟,取上清液,装瓶即得外用中药制剂。
实验例:为了验证本发明外用中药制剂的效果,从2011年1月到2014年1月在10所医院,选取了400例癌症患者进行了药物的实验(实施例5),分为对照组和实验组,对照组200人,实验组200人,对照组使用其他治疗癌痛的西药(如盐酸吗啡片、盐酸布桂嗪片等常规治疗癌痛的药物),实验组使用本发明所得中药制剂,使用方法:为使本发明达到最佳的治疗效果,每次取制备好的中药制剂2-6ml,涂抹在疼痛的部位,反复打圈,轻轻按压3-6下,10天为一个疗程。判定标准:有效:用药后,疼痛基本得到控制,能迅速的减轻疼痛,无效:疼痛无变化,并精确的对数据进行了统计和数理分析。
具体实验结果如下表:
表1:
使用期间患者自感症状如表2所示:
表2:
经临床试验证明,使用本发明外用中药制剂与西医治疗癌症的手段相比,治愈后复发率低,治疗手段更为全面彻底,使用期间无副作用,在治疗癌症的同时,可以缓解由癌症带来的疼痛、食欲不振等症状。经临床试验证明,本发明中药药剂有效率为99%,对于早期及晚期癌症均有良好的治疗作用,大多数癌症患者在用药2天左右,疼痛症状有明显减轻。使用本发明外用中药制剂,在有效控制癌痛的同时,能够使患者的生活质量提高,增加对于未来生活的信心。因此本发明外用中药制剂是一种安全有效的治疗癌痛的药物。
Claims (10)
1.一种减缓癌痛的外用中药制剂,其特征在于:取下述重量配比的主要原料制备而成:元胡3-7份、丹参6-12份、乌药3-8份、蚤休1-5份、土元1-5份、血蝎1-3份,细辛5-15份、透骨草6-13份、乳香7-14份、没药3-9份、大黄7-15份、白芷10-20份、冰片4-10份、漆姑草2-6份、蜘蛛香3-6份、麦饭石2-7份。
2.根据权利要求1所述的减缓癌痛的外用中药制剂,其特征在于:取下述重量配比的主要原料制备而成:元胡4-6份、丹参8-10份、乌药5-7份、蚤休2-4份、土元2-4份、血蝎1.5-2.5份,细辛8-13份、透骨草8-11份、乳香9-12份、没药5-7份、大黄10-12份、白芷13-18份、冰片6-8份、漆姑草3-5份、蜘蛛香4-5份、麦饭石3-6份。
3.根据权利要求1所述的减缓癌痛的外用中药制剂,其特征在于:取下述重量配比的主要原料制备而成:元胡5份、丹参9份、乌药6份、蚤休3份、土元3份、血蝎2份,细辛10份、透骨草10份、乳香11份、没药6份、大黄11份、白芷15份、冰片7份、漆姑草4份、蜘蛛香4.5份、麦饭石5份。
4.根据权利要求1-3任一项所述的减缓癌痛的外用中药制剂的制备方法,其特征在于:步骤如下:
(1)将麦饭石打成指甲盖大小的块,至于特质容器内,于无烟的炉火中锻制酥脆,放凉,研磨成细末待用;
(2)将土元和血蝎用白醋浸泡1-5小时,取出,置于微波炉内,80-90℃,烘1-5分钟,取出,研磨成细末待用;
(3)将元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香拣去杂质、洗净、切丝,置于非铁质容器内,加入白酒,密封静置10-20小时,取出,置于烧热的铁板上,摊匀,小火慢烘20-30分钟,放凉,用研钵研磨成细末待用;
(4)将步骤(1)-(3)所得细末混匀,至于砂锅内加30-40℃的温水,武火煎开,煮沸1-6分钟,转文火煎40-60分钟,然后放入大蒜精文火续煎煮至有大蒜味飘出,放入蜂胶,再次煎煮10-20分钟,加入蜂胶后要一边煎煮一边搅拌,静置50-100分钟,取上清液,装瓶即得外用中药制剂。
5.根据权利要求4所述的制备方法,其特征在于:步骤(2)将土元和血蝎用白醋浸泡2-4小时(优选的,将土元和血蝎用白醋浸泡3小时)。
6.根据权利要求4所述的制备方法,其特征在于:步骤(2)置于微波炉内,83-88℃,烘2-4分钟(优选的,置于微波炉内,85℃(,烘3分钟)。
7.根据权利要求4所述的制备方法,其特征在于:步骤(3)白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的1-5倍(优选的,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的2-4倍,更加优选的,白酒的用量是元胡、丹参、乌药、蚤休、细辛、透骨草、乳香、没药、大黄、白芷、冰片、漆姑草和蜘蛛香总重量的3倍)。
8.根据权利要求4所述的制备方法,其特征在于:步骤(3)白酒的度数为40-55度(优选的,白酒的度数为48-52度,更加优选的,白酒的度数为50度)。
9.根据权利要求4所述的制备方法,其特征在于:步骤(4)至于砂锅内加33-38℃的温水,武火煎开,煮沸2-5分钟,转文火煎45-55分钟(优选的,至于砂锅内加35℃的温水,武火煎开,煮沸4分钟,转文火煎50分钟)。
10.根据权利要求4所述的制备方法,其特征在于:步骤(4)静置60-90分钟,取上清液(优选的,静置75分钟,取上清液)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410659418.3A CN104435573A (zh) | 2014-11-18 | 2014-11-18 | 一种减缓癌痛的外用中药制剂及制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410659418.3A CN104435573A (zh) | 2014-11-18 | 2014-11-18 | 一种减缓癌痛的外用中药制剂及制法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104435573A true CN104435573A (zh) | 2015-03-25 |
Family
ID=52882834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410659418.3A Pending CN104435573A (zh) | 2014-11-18 | 2014-11-18 | 一种减缓癌痛的外用中药制剂及制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435573A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491638A (zh) * | 2014-11-18 | 2015-04-08 | 卢言平 | 一种减缓癌细胞扩散的中药口服液及制法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1109770A (zh) * | 1994-08-31 | 1995-10-11 | 北京市天然百草医药保健技术研究所 | 冰蟾消肿止痛膏及其中药配方和制备方法 |
CN101310753A (zh) * | 2007-05-22 | 2008-11-26 | 王孟 | 一种镇痛抗癌的膏药及其制备方法 |
-
2014
- 2014-11-18 CN CN201410659418.3A patent/CN104435573A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1109770A (zh) * | 1994-08-31 | 1995-10-11 | 北京市天然百草医药保健技术研究所 | 冰蟾消肿止痛膏及其中药配方和制备方法 |
CN101310753A (zh) * | 2007-05-22 | 2008-11-26 | 王孟 | 一种镇痛抗癌的膏药及其制备方法 |
Non-Patent Citations (2)
Title |
---|
唐志英: "外用中药酊剂治疗癌性疼痛35例", 《中医外治杂志》 * |
杨鹏飞: "玄通抗癌方药配合博生癌宁治癌痛40例", 《陕西中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104491638A (zh) * | 2014-11-18 | 2015-04-08 | 卢言平 | 一种减缓癌细胞扩散的中药口服液及制法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463297B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法和用途 | |
CN103071116B (zh) | 治疗食道癌的中药制剂及其制备方法 | |
CN102813900B (zh) | 一种治疗脚鸡眼的外用药 | |
CN105079147A (zh) | 一种无烟艾灸香及其制备方法 | |
CN1132616C (zh) | 一种治疗痹证病的中药 | |
CN103100047B (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN103055266A (zh) | 一种治疗肝癌的中药组合物及其制备方法 | |
CN103611021B (zh) | 用于治疗猪膀胱炎的药物及其制备方法 | |
CN104998197A (zh) | 一种用于治疗肝癌的中药组合物 | |
CN104435544A (zh) | 一种配合化疗治疗白血症的中药口服液及制法 | |
CN104547250A (zh) | 一种抑制癌细胞扩散的中药组合物及其制备方法 | |
CN108853424A (zh) | 治疗乳腺增生的腹灸组合物及其制备方法 | |
CN104435573A (zh) | 一种减缓癌痛的外用中药制剂及制法 | |
CN106389550A (zh) | 治疗带状疱疹的中药 | |
CN104474218A (zh) | 一种减缓癌细胞扩散的健胃消积冲剂及制法 | |
CN114886959B (zh) | 一种药物组合物及其制剂和应用 | |
CN103251779B (zh) | 专治猪冻伤的中药药膏 | |
CN101239109B (zh) | 消除骨刺的外用膏剂及制备工艺 | |
CN103735915B (zh) | 一种治疗食道癌的药物及制备方法 | |
CN108969737A (zh) | 一种治疗产后腹痛与痛经的腹灸组合物及其制备方法 | |
CN106389657A (zh) | 一种治疗前列腺肥大的口服药及其生产方法 | |
CN104491638A (zh) | 一种减缓癌细胞扩散的中药口服液及制法 | |
CN104623601B (zh) | 一种外用祛痛油剂及制备方法 | |
CN105641422A (zh) | 一种用于治疗甲状腺机能亢进症的中药汤剂 | |
CN104840758A (zh) | 一种治疗痛经的中药组合物及制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |